Information Provided By:
Fly News Breaks for July 15, 2015
RCPT, CELG
Jul 15, 2015 | 07:46 EDT
Baird believes Celgene's (CELG) acquisition of Receptos (RCPT) will be viewed favorably by the Street, as the firm sees the price as attractive enough to move the needle for Celgene in the long term. Baird reiterated its Outperform rating and raised its price target to $162 from $139 on Celgene shares.
News For CELG;RCPT From the Last 2 Days
There are no results for your query CELG;RCPT